Europe's pharmaceutical industry is notoriously opaque – and powerful. Big Pharma doesn't want us to know how they determine the prices of the medicines they market, where they store their profits or to whom they hand out millions in funding. The Investigate Europe's investigation Deadly Prices revealed that millions of Europeans lack access to medicines that save or prolong lives in other European countries, and in six EU countries one in four of 32 important medicines analysed is missing, often because they are priced out of reach. This presentation will share tips and techniques on how to investigate Big Pharma – and be transparent about what still remains hidden. From using company and national data that can reveal the true costs of critical medicines to finding public disclosure data that shows who and where the industry's millions go, we will help you with ideas and case studies on how to scrutinise Europe's secretive pharmaceutical world.
